Anna Wolska-Washer

6PUBLICATIONS
3CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Clinical pharmacology and therapeuticsCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 04, 2024
The role of antibody therapies in treating relapsed chronic lymphocytic leukemia: a review.

Magdalena Witkowska, Agata Majchrzak, Paweł Robak

|Oct 03, 2024
BCL-2 and BTK inhibitors for chronic lymphocytic leukemia: current treatments and overcoming resistance.

Tadeusz Robak, Magdalena Witkowska, Anna Wolska-Washer

|Mar 22, 2024
Metabolic and toxicological considerations of Bruton's tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma.

Anna Wolska-Washer, Paweł Robak, Magdalena Witkowska

|Sep 15, 2023
Metabolic and toxicological considerations for phosphoinositide 3-kinase delta inhibitors in the treatment of chronic lymphocytic leukemia.

Magdalena Witkowska, Agata Majchrzak, Paweł Robak

|Mar 17, 2022
Acalabrutinib: a bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia.

Anna Wolska-Washer, Tadeusz Robak

Pageof 1